ALFA Filings
Every announcement, straight from the exchange
Every Panacea Biotec other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Panacea Biotec sent reminder letters to physical shareholders requesting PAN and KYC updates per SEBI circulars. No transaction or business event is involved.
Panacea Biotec Limited has submitted its monthly share dematerialization report for August 2026. This is a routine regulatory compliance filing under SEBI Regulation 74(5).
Panacea Biotec filed its FY2026 Annual Secretarial Compliance Report. The report notes a minor ₹0.02 Crore penalty for a prior dividend intimation delay.
Panacea Biotec Ltd submitted a compliance certificate for the quarter ended March 31, 2026, under SEBI (Depositories and Participants) Regulations. The certificate, issued by Skyline Financial Services, confirms that physical share certificates received for dematerialization were processed, cancelled, and substituted with the depository's name within the mandated 15-day period.
Panacea Biotec Ltd reported its monthly dematerialisation status for March 2026. The company confirmed that no shares were dematerialised during the month, with the total demat holding remaining stable at 6,11,04,526 shares across NSDL and CDSL.